StockData
Alterity Therapeutics Ltd logo

Alterity Therapeutics Ltd (ATHE) stock

ATHENasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRNAF
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Aug 28, 2026Score 5/30
$1.70−0.17 (-8.85%)

Close on Nov 18, 2026Market cap $30.81MP/E –Yield –

Alterity Therapeutics free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2026 it was -A$22.52M. The highest annual figure on record is -A$5.89M in fiscal 2017.

Annual free cash flow

PeriodPeriod endValueChange
FY2026Jun 30, 2026-A$22.52M–
FY2025Jun 30, 2025-A$11.45M–
FY2024Jun 30, 2024-A$12.61M–
FY2023Jun 30, 2023-A$20.04M–
FY2022Jun 30, 2022-A$12.43M–
FY2021Jun 30, 2021-A$17.34M–
FY2020Jun 30, 2020-A$9.45M–
FY2019Jun 30, 2019-A$13.96M–
FY2018Jun 30, 2018-A$6.31M–
FY2017Jun 30, 2017-A$5.89M–
FY2016Jun 30, 2016-A$7.42M–

More Alterity Therapeutics figures

See a number that looks wrong?